Drug
Shr9146 Shr 1210
Shr9146 Shr 1210: highest development phase Phase 1, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR9146+SHR-1210 NCT03491631 | Phase 1 | Tumor, Solid |
Latest
No recent events.
Follow Shr9146 Shr 1210 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.